These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 4775869

  • 1. The effect of a low-protein diet on the pharmacological action of some neutropic drugs.
    Szafranowa H, Krysicka-Doczkal H, Wutkiewicz M.
    Pol J Pharmacol Pharm; 1973; 25(2):135-43. PubMed ID: 4775869
    [No Abstract] [Full Text] [Related]

  • 2. Studies on some aspects of the neuropharmacology of butylurea.
    Dar MS, Fakouhi T.
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):204-12. PubMed ID: 4854473
    [No Abstract] [Full Text] [Related]

  • 3. [Modification of the alcohol effect by valepotriate].
    von Eickstedt KW.
    Arzneimittelforschung; 1969 Jun; 19(6):995-7. PubMed ID: 5820046
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of alaphen on some functions of central nervous system].
    Masiuta GF.
    Farmakol Toksikol; 1966 Jun; 29(5):524-7. PubMed ID: 5995061
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4[H)-quinazolinone (SL-164).
    Saito C, Sakai S, Yukawa Y, Yamamoto H, Takagi H.
    Arzneimittelforschung; 1969 Dec; 19(12):1945-9. PubMed ID: 4985336
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [On the mechanisms of potentiation of the hypnotic effect of some barbiturates by chlorazicin, spasmsolytin and aminazine].
    Vikhliaev IuI, Avakumov VM.
    Farmakol Toksikol; 1967 Dec; 30(3):283-6. PubMed ID: 4386183
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Enhancement and inhibition of stimulating amphetamine effects by drugs with central-depressant properties].
    Müller H, Schoetensack W.
    Naunyn Schmiedebergs Arch Pharmakol; 1969 Dec; 264(3):285-7. PubMed ID: 4242429
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Differentiation of neuroleptic and psychosedative effects in screening].
    Ott T, Matthies H.
    Acta Biol Med Ger; 1969 Dec; 22(5):815-8. PubMed ID: 5392750
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and pharmacological properties of 2,4-disubstituted 5-amino-6-pyrimidinecarboxylic acid derivatives. Part III.
    Jasztold-Howorko R, Machoń Z, Wilimowski M, Wojewódzki W, Barczyńska J, Kedzierska L, Orzechowska-Juzwenko K, Duś E, Dziewiszek W, Rutkowska M.
    Pol J Pharmacol; 1995 Dec; 47(5):435-40. PubMed ID: 8868136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.